Balance Sheets-Additional Information

12 Months Ended

Jun. 30, 2016

Balance Sheets Additional Information [Abstract]

Balance Sheets-Additional Information

4.      Balance Sheets—Additional Information

As of June 30	2016			2015
Accounts receivable, net
Trade accounts receivable		$	128,743		$	114,477
Allowance for doubtful accounts			(4,953)			(3,378)
		$	123,790		$	111,099

As of June 30	2016			2015			2014
Allowance for doubtful accounts
Balance at beginning of period		$	3,378		$	1,235		$	658
Provision for bad debts			1,774			2,587			226
Effect of changes in exchange rates			(132)			(218)			351
Bad debt write-offs (recovery)			(67)			(226)			—
Balance at end of period		$	4,953		$	3,378		$	1,235

As of June 30	2016			2015
Inventories
Raw materials		$	51,369		$	40,012
Work-in-process			8,074			7,617
Finished goods			108,248			102,157
		$	167,691		$	149,786

As of June 30	2016			2015
Property, plant and equipment, net
Land		$	9,612		$	9,130
Buildings and improvements			64,265			50,276
Machinery and equipment			196,480			171,797
			270,357			231,203
Accumulated depreciation			(143,034)			(126,789)
		$	127,323		$	104,414

Certain facilities in Israel are on land leased for a nominal amount from the Israel Land Authority. The lease expires in July 2062. Certain facilities in Israel are on leased land. The leases expire in November 2035.

Net equipment under capital leases was $12 and $48 at June 30, 2016 and 2015, respectively, including accumulated depreciation of  $10 and $42, respectively.

Property, plant and equipment, net includes internal-use software costs, net of accumulated depreciation, of $5,180 and $6,747 at June 30, 2016 and 2015, respectively.

Machinery and equipment includes construction-in-progress of $5,595 and $5,748 at June 30, 2016 and 2015, respectively.

As of June 30	Weighted- Average Useful Life (Years)		2016			2015
Intangibles, net
Cost
Medicated feed additive product registrations		10		$	11,744		$	11,753
Amprolium international marketing rights		10			4,292			4,292
Customer relationships		13			10,606			10,615
Technology		13			66,960			38,580
Distribution agreements		4			3,275			3,298
Trade names, trademarks and other		5			2,740			2,740
In-process research and development					1,579			1,579
					101,196			72,857
Accumulated amortization
Medicated feed additive product registrations					(10,846)			(10,669)
Amprolium international marketing rights					(4,292)			(4,292)
Customer relationships					(6,303)			(5,267)
Technology					(13,877)			(9,741)
Distribution agreements					(3,275)			(3,298)
Trade names, trademarks and other					(2,508)			(2,309)
					(41,101)			(35,576)
				$	60,095		$	37,281

As of June 30	2016			2015
Goodwill roll-forward
Balance at beginning of period		$	12,613		$	12,613
MVP acquisition			8,508			—
Balance at end of period		$	21,121		$	12,613

As of June 30	2016			2015
Other assets
Acquisition-related note receivable		$	5,000		$	5,000
Equity method investments			4,580			4,725
Insurance investments			4,833			4,788
Deferred financing fees			3,602			4,335
Deferred income taxes			28,019			221
Deposits			5,992			532
Other			6,977			5,681
		$	59,003		$	25,282

We evaluate our investments in equity method investees for impairment if circumstances indicate that the fair value of the investment may be impaired. The assets underlying a $4,076 equity investment are currently idled; we have concluded the investment is not currently  impaired, based on expected future operating cash flows and/or disposal value.

As of June 30	2016			2015
Accrued expenses and other current liabilities
Employee related		$	21,712		$	22,273
Commissions and rebates			3,722			4,148
Insurance related			1,780			1,368
Professional fees			3,573			3,543
Income and other taxes			1,910			817
Deferred consideration on acquisitions			1,250			1,196
Fair value of derivatives			—			1,542
Other			11,756			10,576
		$	45,703		$	45,463
Other liabilities
U.S. pension plan		$	21,371		$	18,573
International retirement plans			5,600			4,893
Supplemental retirement benefits, deferred compensation and  other			8,984			7,443
Long term and deferred income taxes			8,205			19,098
Deferred consideration on acquisitions			9,172			7,266
Other long term liabilities			7,981			8,375
		$	61,313		$	65,648

As of June 30	2016			2015
Accumulated other comprehensive income (loss)
Derivative instruments		$	2,655		$	(1,542)
Foreign currency translation adjustment			(41,904)			(32,723)
Unrecognized net pension gains (losses)			(30,977)			(19,884)
(Provision) benefit for income taxes on derivative instruments			(1,548)			63
(Provision) benefit for incomes taxes on long-term intercompany investments			8,166			4,923
(Provision) benefit for income taxes on pension  gains (losses)			1,823			(2,437)
		$	(61,785)		$	(51,600)